Cargando…
ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
INTRODUCTION: One of the most common cancers is hepatocellular carcinoma (HCC), which is an aggressive cancer that is associated with high mortality. The expression and role of ARHGAP20 in HCC remain unclear. MATERIALS AND METHODS: The expression and clinical role of ARHGAP20 were investigated using...
Autores principales: | Liu, Gao, Li, Jia, Zhang, Cai-Yun, Huang, Dong-Yang, Xu, Ji-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071084/ https://www.ncbi.nlm.nih.gov/pubmed/33907697 http://dx.doi.org/10.2147/JHC.S298554 |
Ejemplares similares
-
Knockdown of ARHGAP30 inhibits ovarian cancer cell proliferation, migration, and invasiveness by suppressing the PI3K/AKT/mTOR signaling pathway
por: Chu, Xiaoyan, et al.
Publicado: (2023) -
ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma
por: Hu, Qian, et al.
Publicado: (2018) -
ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway
por: Lin, Lan-Lan, et al.
Publicado: (2021) -
Knockdown of FOXO6 Inhibits Glycolysis and Reduces Cell Resistance to Paclitaxel in HCC Cells via PI3K/Akt Signaling Pathway
por: Yu, Xixiang, et al.
Publicado: (2020) -
NAP1L5 targeting combined with MYH9 Inhibit HCC progression through PI3K/AKT/mTOR signaling pathway
por: Zhao, Rui, et al.
Publicado: (2022)